BER Stock Overview
Bioerg Spólka Akcyjna engages in the retail trade of food and chemical products for humans and animals in Poland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Bioerg Spólka Akcyjna Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.14 |
52 Week High | zł0.29 |
52 Week Low | zł0.13 |
Beta | 1.02 |
1 Month Change | 0% |
3 Month Change | -5.57% |
1 Year Change | -17.63% |
3 Year Change | 133.62% |
5 Year Change | 50.56% |
Change since IPO | -80.64% |
Recent News & Updates
Shareholder Returns
BER | PL Biotechs | PL Market | |
---|---|---|---|
7D | 0% | 1.1% | 0.8% |
1Y | -17.6% | -20.0% | 34.8% |
Rentabilidad frente al sector: BER obtuvo unos resultados inferiores a los del sector Polish Biotechs , que el año pasado arrojó un rendimiento del -8.8%.
Rentabilidad vs. Mercado: BER obtuvo unos resultados inferiores a los del mercado Polish, que fue del 24.7% el año pasado.
Price Volatility
BER volatility | |
---|---|
BER Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in PL Market | 9.5% |
10% least volatile stocks in PL Market | 3.2% |
Precio estable de las acciones: BER no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de BER en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 1 | Piotr Klomfas | https://www.bioerg.pl |
Bioerg Spólka Akcyjna Fundamentals Summary
BER fundamental statistics | |
---|---|
Market cap | zł13.78m |
Earnings (TTM) | -zł66.00k |
Revenue (TTM) | zł299.00k |
46.1x
P/S Ratio-208.8x
P/E RatioIs BER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BER income statement (TTM) | |
---|---|
Revenue | zł299.00k |
Cost of Revenue | zł29.00k |
Gross Profit | zł270.00k |
Other Expenses | zł336.00k |
Earnings | -zł66.00k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 10, 2023
Earnings per share (EPS) | -0.00065 |
Gross Margin | 90.30% |
Net Profit Margin | -22.07% |
Debt/Equity Ratio | 123.6% |
How did BER perform over the long term?
See historical performance and comparison